Bringing the fundamentals into focus…
Back to Neumora Therapeutics, Inc.
How Neumora Therapeutics, Inc. stacks up
NMRA · against 105 other Healthcare companies of similar size
Overall
31/ 100
Near the bottom of its peers.
Ranked #80 of 106 · scores higher than 23% of peers
Bars: peers in each 10-point band of the overall score28 peers with an overall score of 30–39, including NMRA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around NMRA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 592M ILS (≈$160M) | 84 | 99 | 99 | 96 | 1 / 2 | |
| 2 | 178.5B KRW (≈$129M) | 76 | 91 | 55 | 77 | 0 / 2 | |
| 2 | 6.5B TWD (≈$200M) | 76 | 83 | 78 | 56 | 0 / 2 | |
| 4 | 1.1B HKD (≈$146M) | 72 | 99 | 53 | 80 | 1 / 2 | |
| 4 | 244.2B KRW (≈$176M) | 72 | 84 | 58 | 83 | 1 / 2 | |
| 76 | 60M USD | 33 | 29 | 33 | 1 / 2 | ||
| 76 | 184M USD | 33 | 33 | 4 | 3 | 0 / 2 | |
| 78 | 126M USD | 32 | 33 | 84 | 10 | 2 / 2 | |
| 78 | 139M USD | 32 | 8 | 55 | 15 | 1 / 2 | |
| 80 | 107M USD | 31 | 75 | — | 15 | 2 / 2 | |
| 80 | 124M USD | 31 | 8 | 81 | 22 | 2 / 2 | |
| 80 | 89M USD | 31 | 33 | — | 2 | 1 / 2 | |
| 83 | 200M USD | 30 | 46 | 26 | 2 / 2 | ||
| 84 | 649M SEK (≈$65M) | 29 | 8 | 99 | 7 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score